Incidence of hand–foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen
作者： Antonio Irigoyen , Beatriz Llorente , Begoña Pérez , Raquel Serrano , Mª José Safont
DOI: 10.1007/S12094-012-0858-3
关键词:
摘要: Introduction Hand–foot syndrome (HFS) is a limiting toxicity of capecitabine, which not life-threatening but could compromise capecitabine efficacy.
springer.com
unirioja.es
sci-hub.se 参考文章(24)
A Webb, D Cunningham, J H Scarffe, P Harper, A Norman, J K Joffe, M Hughes, J Mansi, M Findlay, A Hill, J Oates, M Nicolson, T Hickish, M O'Brien, T Iveson, M Watson, C Underhill, A Wardley, M Meehan, Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. Journal of Clinical Oncology. ,vol. 15, pp. 261- 267 ,(1997) , 10.1200/JCO.1997.15.1.261
Yoon-Koo Kang, Min-Hee Ryu, Changhoon Yoo, Heung-Moon Chang, Jeong Hwan Yook, Sung Tae Oh, Byung Sik Kim, Tae Won Kim, Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer. Cancer Chemotherapy and Pharmacology. ,vol. 67, pp. 1435- 1443 ,(2011) , 10.1007/S00280-010-1444-4
Eduardo Nagore, Amelia Insa, Onofre Sanmart??n, Antineoplastic therapy-induced palmar plantar erythrodysesthesia ('hand-foot') syndrome. Incidence, recognition and management. American Journal of Clinical Dermatology. ,vol. 1, pp. 225- 234 ,(2000) , 10.2165/00128071-200001040-00004
Jacques Ferlay, Hai-Rim Shin, Freddie Bray, David Forman, Colin Mathers, Donald Maxwell Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. ,vol. 127, pp. 2893- 2917 ,(2010) , 10.1002/IJC.25516
Noe Kyeong Kim, Young Suk Park, Dae Seog Heo, Cheolwon Suh, Si Young Kim, Keun Chil Park, Yoon Koo Kang, Dong Bok Shin, Heung Tae Kim, Hyo Jin Kim, Won Ki Kang, Chang In Suh, Yung-Jue Bang, A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer Cancer. ,vol. 71, pp. 3813- 3818 ,(1993) , 10.1002/1097-0142(19930615)71:12<3813::AID-CNCR2820711205>3.0.CO;2-5
D L Schipper, D J T Wagener, Chemotherapy of gastric cancer. Anti-Cancer Drugs. ,vol. 7, pp. 137- 149 ,(1996) , 10.1097/00001813-199602000-00001
Joan D. Webster-Gandy, Chris How, Karen Harrold, Palmar-plantar Erythrodysesthesia (PPE): A Literature Review With Commentary on Experience in a Cancer Centre European Journal of Oncology Nursing. ,vol. 11, pp. 238- 246 ,(2007) , 10.1016/J.EJON.2006.10.004
Samer Abushullaih, Everardo D. Saad, Mark Munsell, Paulo M. Hoff, Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: a single-institution experience. Cancer Investigation. ,vol. 20, pp. 3- 10 ,(2002) , 10.1081/CNV-120000360
G Norman, M Soares, P Peura, S Rice, D Suh, K Wright, M Sculpher, A Eastwood, Capecitabine for the treatment of advanced gastric cancer. Health Technology Assessment. ,vol. 14, pp. 11- 17 ,(2010) , 10.3310/HTA14SUPPL2/02
A. Webb, D. Cunningham, F. Cotter, P. Ross, J. Walters, I. Judson, F. Raynaud, P. Clarke, Z.E. Dziewanowska, First demonstration of anti-lymphoma activity of BCL-2 antisense molecule-G3139; Results of phase I/IIA clinical trial European Journal of Cancer. ,vol. 33, ,(1997) , 10.1016/S0959-8049(97)86090-X